Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus

AAPS PharmSciTech

Volumn 9, Issue 1, 2008, Pages 13-21

  Borhade, Vivek ^a   Nair, Hema ^a   Hegde, Darshana ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

Emulsification efficiency; Poorly water soluble; SMEDDS; Tacrolimus (FK506)

Indexed keywords

BUFFER; COSURFACTANT; OIL; SURFACTANT; TACROLIMUS; DRUG CARRIER; EMULSIFYING AGENT;

ARTICLE; CONTROLLED STUDY; DILUTION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG MARKETING; DRUG SOLUBILITY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MICROEMULSION; MOUSE; NONHUMAN; PH MEASUREMENT; PHASE SEPARATION; PRECIPITATION; PROCESS OPTIMIZATION; SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEM; CHEMISTRY; DIFFUSION; DRUG DESIGN; DRUG FORMULATION; DRUG SCREENING; EVALUATION; MATERIALS TESTING; METHODOLOGY; PHASE TRANSITION; SOLUBILITY;

DIFFUSION; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; EMULSIFYING AGENTS; MATERIALS TESTING; PHASE TRANSITION; SOLUBILITY; TACROLIMUS;

EID: 44849087456     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-007-9014-8     Document Type: Article

References (23)

1. C. M. Spencer, K. L. Goa, and J. C. Gillis. Tacrolimus: An update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs 54:925-975 (1997).
2. R. Shapiro. Tacrolimus in solid organ transplantation: An update. Transpl. Proc. 31:2203-2205 (1999).
3. E. Christine, and E. Susan. Clinical pharmacokinetics and pharmacodynamics of FK 506 in solid organ transplantation. Clin. Pharmacokinet. 43:623-653 (2004).
4. T. Kino, H. Hatanaka, M. Hashimoto, M. Nishiyama, T. Goto, M. Okuhara, and M. Kohsaka. FK 506, a novel immunosuppressant isolated from a Streptomyces I. Fermentation, isolation and physico-chemical and biological characteristics. J. Antibiot. 42: 1249-1255 (1987).
5. T. Shigeki, O. Atsuo, I. Rinta, and L. Gordon. Tacrolimus is a class II low-solubility high permeability drug: The effect of P-glycoprotein efflux on regional permeability of tacrolimus in rats. J. Pharm. Sci. 91:719-729 (2002).
6. M. Shimomura, S. Masuda, H. Saito, S. Sakamoto, S. Uemoto, K. Tanaka, and K. Inui. Roles of the Jejunum and ileum in the first-pass effect as absorptive barriers for orally administered tacrolimus. J. Surg. Res. 103:215-222 (2002).
7. T. Honbo, M. Kobayashi, K. Hane, T. Hata, and Y. Ueda. The oral dosage form of FK 506. Transpl. Proc. 19: 17-22 (1987).
8. K. Yamashita, T. Nakate, K. Okimoto, K. Higaki, and T. Kimura. Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int. J. Pharm. 267:79-91 (2003).
9. H. Arima, K. Yunomae, K. Miyake, T. Irie, F. Hirayama, and K. Uekama. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats. J. Pharm. Sci. 90:690-701 (2001).
10. V. C. McAlister, M. Keshavamurthy, and T. D. G. Lee. Oral delivery of liposomal tacrolimus: Increased efficacy and reduced toxicity. Transplant. Proc. 31:1110-1113 (1999).
11. R. N. Gursoy, and S. Benita. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 58:173-182 (2004).
12. M. J. Lawrence, and G. D. Rees. Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv. Rev. 45:89-121 (2000).
13. C. W. Pouton. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur. J. Pharm. Sci. 11 Supplement: S93-S98 (2000).
14. J. Vonderscher, and A. Meinzer. Rationale for the development of Sandimmune Neoral. Transplant Proc. 26:2925-2927 (1994).
15. T. Gershanika, and S. Benita. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur. J. Pharm. Biopharm. 50:179-188 (2000).
16. V. B. Borhade. Study of specialized emulsions for drug delivery (Masters thesis). University of Mumbai, India, 2006.
17. C. V. Corswant, and O. Söderman. Microemulsions based on soybean phosphotidylcholine and triglycerides: Phase behavior and microstructure. Langmuir 13:5061-5070 (1997).
18. S. J. Kim, H. K. Choi, and Y. B. Lee. Pharmacokinetic and pharmacodynamic evaluation of cyclosporin A o/w emulsion in rats. Int. J. Pharm. 249:149-156 (2002).
19. K. Kawakami, T. Yoshikawa, Y. Moroto, E. Kanaoka, K. Takahashi, Y. Nishihara, and K. Masuda. Microemulsion formulation for enhanced absorption of poorly soluble drugs I. Prescription design. J. Control. Rel. 81:65-74 (2002).
20. C. Malcolmson, A. Sidhu, C. Satra, S. Kantaria, and M. J. Lawrence. Effect of the nature of oil on the incorporation of testosterone propionate into non ionic oil-in-water microemulsions. J. Pharm. Sci. 87:109-116 (1998).
21. W. Warisnoicharoen, A. B. Lansley, and M. J. Lawrence. Nonionic oil-in-water microemulsions: Effect of oil type on phase behavior. Int. J. Pharm. 198:7-27 (2000).
22. P. Li, A. Ghosh, R. F. Wagner, S. Krill, and Y. M. Joshi. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int. J. Pharm. 288:27-34 (2004).
23. B. K. Kanga, J. S. Lee, S. K. Chona, S. Y. Jeong, G. Khanga, H. B. Lee, and S. H. Choc. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int. J. Pharm. 274:65-73 (2004).